🇺🇸 FDA
Company

Viridian

Viridian Therapeutics, Inc.\DE

VRDN pharma USA

Quick answer

Viridian is a pharma company (VRDN) headquartered in WALTHAM, MA, USA with 6 tracked pipeline programs.

Pipeline (6)

project

VRDN-001 10 mg/kg

Thyroid Eye Disease

Phase 3 · small_molecule · completed

1 trials project

VRDN-001 Phase 3 Cohort (THRIVE)

Thyroid Eye Disease

Phase 3 · small_molecule · completed

1 trials project

VRDN-003

Thyroid Eye Disease

Phase 3 · small_molecule · active

3 trials project

VRDN-003

Thyroid Eye Disease (TED)

Phase 3 · small_molecule · active

1 trials project

Veligrotug

Thyroid Eye Disease

Phase 3 · small_molecule · completed

1 trials project

Veligrotug (VRDN-001)

Thyroid Eye Disease

Phase 3 · small_molecule · completed

1 trials

Patents (3)

patent

US 12404335

Compositions and methods for treatment of thyroid eye disease

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12404337

Compositions, doses, and methods for treatment of thyroid eye disease

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11548951

Compositions and methods for treatment of thyroid eye disease

Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)